Modern ethical, legal and institutional framework of biomedical cell technologies development in the People’s Republic of China

Cover Page


Cite item

Full Text

Abstract

New Chinese medicine democracy almost did not affect the traditional bases of the medical code, a certain pragmatism in relation to the moral component was preserved in it. Interest in the individual’s health was originally inscribed in the worldview code of the Chinese nation, which understands the best way of a living being existence as a harmony of the natural elements, energy states in it. General pantheistic basis, hidden or explicit anthropological naturalism of religious and philosophical views, which are traditional for China, Confucianism, Taoism and Buddhism form had a corresponding impact on medical ethics. Millennium beginning was expressed in the focusing of the government attention on the ethical and legal support of biotechnologies, in particular biomedical cell technologies. Government set targets to accelerate the implementation of the governmental scientific and technological specific projects in innovation areas. As a result of special solutions development by the China’s Communist Party, government emphasized the formation of developed system of «high technology zones», including biotechnoparks. Strict regulatory requirements for production, storage and use of stem cells different types, which have been adopted by the government of the People’s Republic of China in recent years, objectively allow China to sell products and services in the field of cell technology not only domestically but also abroad. If the business component of those services types, which are currently formed in the Chinese industry of biomedical cell technologies, are considered, three models can be distinguished: the first model is related to stem cells collection and storage; the second model includes stem cells production and research; the third business model - enterprises directly engaged with stem cell transplantation.

About the authors

G N Kuz’menko

Russian State Social University

Author for correspondence.
Email: yashik211@rambler.ru

O F Lobazova

Russian State Social University

Email: yashik211@rambler.ru

O A Evreeva

Russian State Social University

Email: yashik211@rambler.ru

References

  1. -й китайский пятилетний план по медицинским технологиям. http://www.chemrar.ru/i-news/index.php?ELEMENT_ID=12899 (дата обращения: 15.05.2015).
  2. Антонов В. Внимание инвесторов приковано к сектору биотехнологий. http://financial-rating.ru/news/theme-of-the-day/46322/ (дата обращения: 21.05.2015).
  3. Духовная культура Китая. Т. 5. Наука, техническая и военная мысль, здравоохранение и образование. Под ред. М.Л. Титаренко. М.: Восточная литература. 2009. http://publ.lib.ru/ARCHIVES/D/’’Duhovnaya_kul’tura_Kitaya’’/_’’Duhovnaya_kul’tura_Kitaya’’.html (дата обращения: 25.05.2015).
  4. Китайская народная республика: государственные программы поддержки инновационной сферы. http://www.gmu-countries.ru/asia/china/nis-programs.html (дата обращения: 29.12.2015).
  5. Клиника Тиантан Пухуа. Обзор лучших медицинских центров и клиник Пекина. Сайт Путешествие в Китай. 2015. http://traveltochina.ru/lechenie/kliniki-pekina.html (дата обращения: 29.12.2015).
  6. Сайт ChinaBio сегодня. http://www.chinabiotoday.com (дата обращения: 29.12.2015).
  7. Семашко Н.А. Об облике советского врача. Избранные произведения. М.: Медгиз. 1954; 339 с.
  8. Стратегия развития биотехнологической отрасли Российской Федерации на 2010-2020 гг. http://www.biorosinfo.ru/papers-society/Strategy_Bioindustry.pdf (дата обращения: 29.12.2015).
  9. Цзинтао Х. Доклад на XVII Всекитайском съезде КПК. http://russian.china.org.cn/china/archive/shiqida/2007-10/25/content_9120930.htm (дата обращения: 29.12.2015).
  10. Цзинтао Х. Доклад на XVIII Всекитайском съезде КПК. http://russian.people.com.cn/31521/8023881.html (дата обращения: 21.05.2015).
  11. Ching-Li H., Mingxian S. Review and Perspective of the Bioethics Development in China. https://googledrive.com/host/0B1arYAWdEZhkbnJjcEt2NlY4RTg/review.pdf (access date: 29.12.2015).
  12. Li C.X. Government support, issued thesis patent application of stem cell research. J. Clin. Rehabilit. Tissue Engineering Research. 2007; 11 (15): 2913-2918. http://www.doc88.com/p-34289423051.html (access date: 19.04.2015).
  13. Li H., Cong Y. The development and perspectives of Chinese bioethics. J. Int. Bioethique. 2008; 19 (4): 21-32, 159. http://www.ncbi.nlm.nih.gov/pubmed/19492719 (access date: 19.05.2015). http://dx.doi.org/10.3917/jib.194.0021
  14. Rotman S. China’s biotech industry: An Asian dragon is growing. Nature Biotechn. http://www.eurekalert.org/pub_releases/2008-01/pols-cbi010108.php (access date: 29.12.2015).
  15. Shaheen E.L. The emergence of modern biotechnology in china. 1999-2015. Rice University. Creative Commons. http://cnx.org/contents/VLu9AAyL@1/The-Emergence-of-Modern-Biotec (access date: 29.12.2015).
  16. Website China National Health Developent Research Center (Сайт Китайского национального исследовательского центра развития здоровья). http://www.nhei.cn/nhei_en/center_en/web/index.jsp (access date: 29.12.2015).
  17. Website National Health and Family Planning Commission of the PRC (Сайт Комиссии национального здравоохранения и планирования семьи КНР). http://www.nhfpc.gov.cn/ (access date: 29.12.2015).
  18. Zailin Y., Yuehan D. The development of China’s medical biotech industry needs to be driven by innovation. Biotechnol. J. Special Issue: Biotech in China. 2006; 1 (11): 1253-1257. http://onlinelibrary.wiley.com/doi/10.1002/biot.200600086/abstract (access date: 29.12.2015).
  19. Zhang L. China leading the world for growth in high-quality science output, Nature Index shows. 2015. Macmillan Publishers Limited. Nature Publishing Group (NPG). http://www.nature.com/press_releases/nature-index-china-2015.html (access date: 29.12.2015).

Supplementary files

Supplementary Files
Action
1. JATS XML

© 2016 Kuz’menko G.N., Lobazova O.F., Evreeva O.A.

Creative Commons License

This work is licensed
under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.





This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies